US 9,642,838 · Application 14/876,447 · Granted May 9, 2017
US 9,642,838
Compounds and compositions that bind and stabilize transthyretin and their use for inhibiting transthyretin amyloidosis and protein-protein interactions
Estimated expiration
May 5, 2031
4y 230d remaining
Earliest effective filing
Mar 14, 2013
+ 20 years
Mar 14, 2033
PTA +0d
Mar 14, 2033
TD cap (US 8,877,795)
May 5, 2031
Final
May 5, 2031
This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included. Terminal disclaimers can affect PTA (In re Cellect, LLC).
Calculation details
Base term
- Filing date
- October 6, 2015
- Earliest effective filing
- March 14, 2013
- Issue date
- May 9, 2017
- PTA
- 0 days
- Base expiry (before PTA)
- March 14, 2033
March 14, 2013 + 20 years = March 14, 2033
- Continuation of application 13/830,731, filed Mar 14, 2013, issued as US 9,169,214
- PRO61/745,089 — Provisional — not used for base term
- PRO61/745,089 — Provisional — not used for base term
Terminal disclaimers
TD caps expiration to May 5, 2031 (earliest expiring referenced patent: US 8,877,795)
US 9,913,826· Application 15/480,139Capping patent
Compounds and compositions that bind and stabilize transthyretin and their use for inhibiting transthyretin amyloidosis and protein-protein interactions
- Filing date
- Apr 5, 2017
- Earliest effective filing
- Mar 14, 2013
- Issue date
- Mar 13, 2018
- PTA
- 0 days
- Calculated expiration
- Mar 14, 2033
Continuation of 14/876,447, filed Oct 6, 2015, issued as US 9,642,838
Continuation of 13/830,731, filed Mar 14, 2013, issued as US 9,169,214
Continuation of 13/830,731, filed Mar 14, 2013, issued as US 9,169,214
Mar 14, 2013 + 20y = Mar 14, 2033
US 10,398,681· Application 15/883,750
Compounds and compositions that bind and stabilize transthyretin and their use for inhibiting transthyretin amyloidosis and protein-protein interactions
- Filing date
- Jan 30, 2018
- Earliest effective filing
- Mar 14, 2013
- Issue date
- Sep 3, 2019
- PTA
- 0 days
- Calculated expiration
- Mar 14, 2033
Continuation of 15/480,139, filed Apr 5, 2017, issued as US 9,913,826
Continuation of 14/876,447, filed Oct 6, 2015, issued as US 9,642,838
Continuation of 13/830,731, filed Mar 14, 2013, issued as US 9,169,214
Continuation of 13/830,731, filed Mar 14, 2013, issued as US 9,169,214
Continuation of 14/876,447, filed Oct 6, 2015, issued as US 9,642,838
Continuation of 13/830,731, filed Mar 14, 2013, issued as US 9,169,214
Mar 14, 2013 + 20y = Mar 14, 2033
US 10,842,777· Application 16/510,574
Compounds and compositions that bind and stabilize transthyretin and their use for inhibiting transthyretin amyloidosis and protein-protein interactions
- Filing date
- Jul 12, 2019
- Earliest effective filing
- Mar 14, 2013
- Issue date
- Nov 24, 2020
- PTA
- 0 days
- Calculated expiration
- Mar 14, 2033
Continuation of 15/883,750, filed Jan 30, 2018, issued as US 10,398,681
Continuation of 15/480,139, filed Apr 5, 2017, issued as US 9,913,826
Continuation of 14/876,447, filed Oct 6, 2015, issued as US 9,642,838
Continuation of 13/830,731, filed Mar 14, 2013, issued as US 9,169,214
Continuation of 13/830,731, filed Mar 14, 2013, issued as US 9,169,214
Continuation of 14/876,447, filed Oct 6, 2015, issued as US 9,642,838
Continuation of 13/830,731, filed Mar 14, 2013, issued as US 9,169,214
Continuation of 15/480,139, filed Apr 5, 2017, issued as US 9,913,826
Continuation of 14/876,447, filed Oct 6, 2015, issued as US 9,642,838
Continuation of 13/830,731, filed Mar 14, 2013, issued as US 9,169,214
Mar 14, 2013 + 20y = Mar 14, 2033
US 8,877,795· Application 13/696,505Capping patent
Identification of stabilizers of multimeric proteins
- Filing date
- Jan 23, 2013
- Earliest effective filing
- May 5, 2011
- Issue date
- Nov 4, 2014
- PTA
- 0 days
- Calculated expiration
- May 5, 2031
National stage entry of PCTUS2011035350, filed May 5, 2011
May 5, 2011 + 20y = May 5, 2031
US 9,308,209· Application 14/531,888
Identification of stabilizers of multimeric proteins
- Filing date
- Nov 3, 2014
- Earliest effective filing
- May 5, 2011
- Issue date
- Apr 12, 2016
- PTA
- 0 days
- Calculated expiration
- May 5, 2031
Continuation of 13/696,505, filed Jan 23, 2013, issued as US 8,877,795
National stage entry of PCTUS2011035350, filed May 5, 2011
National stage entry of PCTUS2011035350, filed May 5, 2011
May 5, 2011 + 20y = May 5, 2031
Notes (1)
- [TD_REFS_TRUNCATED] Found 11 TD references; resolving first 5 only
Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated
The prosecution record for your AI
Application 14/876,447 · US 9,642,838
You have the date. Your AI can have the file.
PatentReply compiles the prosecution history behind US 9,642,838: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.
One public application a month is free. The first compile takes a few minutes.
Strategy and filing changes require your approval.
Permanent link
www.patentreply.ai/tools/patent-expiration/US9642838Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.